Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib (Q46618741)
Jump to navigation
Jump to search
scientific article published on 25 July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib |
scientific article published on 25 July 2005 |
Statements
1 reference
Mutations in the epidermal growth factor receptor and in KRAS are predictive and prognostic indicators in patients with non-small-cell lung cancer treated with chemotherapy alone and in combination with erlotinib (English)
1 reference
Pasi A Jänne
1 reference
Roy S Herbst
1 reference
David A Eberhard
1 reference
Bruce E Johnson
1 reference
Lukas C Amler
1 reference
Audrey D Goddard
1 reference
Sherry L Heldens
1 reference
William L Ince
1 reference
Thomas Januario
1 reference
David H Johnson
1 reference
Pam Klein
1 reference
Vincent A Miller
1 reference
Michael A Ostland
1 reference
David A Ramies
1 reference
Dragan Sebisanovic
1 reference
Jeremy A Stinson
1 reference
Yu R Zhang
1 reference
Somasekar Seshagiri
1 reference
Kenneth J Hillan
1 reference
25 July 2005
1 reference
1 reference
23
1 reference
5900-5909
1 reference
25
1 reference
Identifiers
1 reference
1 reference